- Trials with a EudraCT protocol (224)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
224 result(s) found for: wound care.
Displaying page 1 of 12.
EudraCT Number: 2017-002669-23 | Sponsor Protocol Number: PROFITOP | Start Date*: 2017-12-21 | |||||||||||
Sponsor Name:Hospital General Universitari de Granollers | |||||||||||||
Full Title: Prophylaxis of surgical wound infection with topical antibiotics | |||||||||||||
Medical condition: Surgical wound infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003390-26 | Sponsor Protocol Number: BSG-12 | Start Date*: 2012-12-18 | |||||||||||
Sponsor Name:Birken AG | |||||||||||||
Full Title: Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 versus Standard of Care in... | |||||||||||||
Medical condition: Split-Thickness Skin Graft Donor Sites | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) GR (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000777-23 | Sponsor Protocol Number: BSH-12 | Start Date*: 2012-07-05 | |||||||||||
Sponsor Name:Birken AG | |||||||||||||
Full Title: Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 versus Standard of Care in... | |||||||||||||
Medical condition: Split-Thickness Skin Graft Donor Sites | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) FI (Completed) AT (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004527-67 | Sponsor Protocol Number: DT-DP-DFU-CR-04 | Start Date*: 2018-08-06 |
Sponsor Name:DermaTools Biotech GmbH | ||
Full Title: A Randomised Dose Finding Study Comparing The Safety And Efficacy Of three blinded doses of Diperoxochloric Acid (DPOCl, DermaPro®) and A Standard Moist Wound Dressing In Patients With Non-Healing... | ||
Medical condition: Diabetic foot ulcer with mean diameter between 1.5 and 4 cm after débridement if indicated), Wound stage Wagner grade I or II, Armstrong stadium A or C (for Wagner-Armstrong-Classification), tr... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) EE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003066-24 | Sponsor Protocol Number: MW2012-01-01 | Start Date*: 2014-12-17 | |||||||||||
Sponsor Name:MediWound Ltd. | |||||||||||||
Full Title: A multicenter, multinational, randomized, controlled, open label study, performed in children with thermal burns, to evaluate the efficacy and safety of NexoBrid as compared to standard of care (SO... | |||||||||||||
Medical condition: The study objective is to evaluate the safety and clinical benefit of NexoBrid in hospitalized children (0-18 years) with deep partial and/or full thickness thermal burns of 1-30% TBSA and to compa... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Ongoing) SK (Completed) DE (Ongoing) BE (Completed) AT (Prematurely Ended) BG (Prematurely Ended) NL (Prematurely Ended) FR (Ongoing) SE (Ongoing) GB (GB - no longer in EU/EEA) HU (Completed) PL (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000476-14 | Sponsor Protocol Number: TCI_BRIVA | Start Date*: 2013-05-07 | |||||||||||
Sponsor Name:LANDSTINGET I ÖSTERGÖTLAND | |||||||||||||
Full Title: TARGET-CONTROLLED INFUSION (TCI) WITH PROPOFOL AND REMIFENTANIL AS ANALGO-SEDATION IN WOUND CARE IN PATIENTS WITH BURNS | |||||||||||||
Medical condition: Burn patients who need analgo-sedation during wound care. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000362-38 | Sponsor Protocol Number: BBW-11 | Start Date*: 2012-06-18 | |||||||||||
Sponsor Name:Birken AG | |||||||||||||
Full Title: Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 versus Standard of Care in... | |||||||||||||
Medical condition: Superficial partial-thickness (grade 2a) burn wounds | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004109-15 | Sponsor Protocol Number: 1ABC | Start Date*: 2017-12-13 | |||||||||||
Sponsor Name:Medical University of Warsaw | |||||||||||||
Full Title: Evaluation of the safety and efficacy of the treatment of chronic wounds in diabetic foot syndrome with the use of autologous stem cells isolated from adipose tissue - within the project: "Therapeu... | |||||||||||||
Medical condition: Diabetic foot ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000563-69 | Sponsor Protocol Number: IPCT003 | Start Date*: 2021-06-04 |
Sponsor Name:Ilya Pharma AB | ||
Full Title: A Randomized, Double-Blind, Placebo-controlled, Parallel, Exploratory Phase 2a Study to Evaluate Safety and Biological Effect on Wound Healing of ILP100 in Subjects with Diabetic Foot Ulcers | ||
Medical condition: Diabetic foot ulcers a systemic complication in diabetes mellitus type 1 or 2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005092-18 | Sponsor Protocol Number: CS I-020502/01 | Start Date*: 2007-01-08 | |||||||||||
Sponsor Name:KUROS BIOSURGERY AG | |||||||||||||
Full Title: A phase 2a, multi-centre, controlled study of the safety and efficacy of wound healing gel I-020502 in patients undergoing autologous meshed skin grafting. | |||||||||||||
Medical condition: Deep partial-thickness and full-thickness burns require grafting procedures to achieve wound healing and closure. Autologous grafting eliminates the risk of transmissible diseases but may be compli... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021015-16 | Sponsor Protocol Number: TFM-CL3-002 | Start Date*: 2010-09-30 | |||||||||||
Sponsor Name:Olympus France SAS | |||||||||||||
Full Title: A Phase III, Double-Blind, Placebo Controlled, Parallel Group, International, Multicenter Study of 12 Weeks Treatment with Trafermin 0.01% Spray in Patients with Diabetic Foot Ulcer of Neuropathic ... | |||||||||||||
Medical condition: Wound closure rate of diabetic foot ulcers (DFUs) of neuropathic origin. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) BE (Completed) DK (Completed) SE (Completed) DE (Completed) NL (Completed) HU (Completed) SK (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001301-90 | Sponsor Protocol Number: SNFCT2017-06 | Start Date*: 2020-05-20 | |||||||||||
Sponsor Name:Sanifit Therapeutics S.A | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When added to Background Care for the Treatment of Calciphylaxis. | |||||||||||||
Medical condition: Calciphylaxis (Calcific uremic arteriolopathy [CUA]) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) ES (Prematurely Ended) PL (Completed) BE (Completed) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004728-14 | Sponsor Protocol Number: TCP25-001 | Start Date*: 2022-03-10 |
Sponsor Name:Xinnate AB | ||
Full Title: A Three-part, Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of Topical Doses of TCP-25 in Healthy Male and Female Volunteers with Epidermal Suction Blister Wounds and in... | ||
Medical condition: TCP-25 gel targets both bacteria and inflammation, aspects common to many wounds and is being developed for a range of wound healing indications including prevention and treatment of infection and ... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003326-23 | Sponsor Protocol Number: DT-DP-DFU-CR-05 | Start Date*: 2021-07-05 |
Sponsor Name:DermaTools Biotech GmbH | ||
Full Title: A Prospective, Randomized, Double-Blind, Vehicle-Controlled Study To Evaluate The Safety and Efficacy of Diperoxochloric Acid (DPOCl, DermaPro®) In Patients With Non-Healing Diabetic Foot Ulcers | ||
Medical condition: 3. Diabetic foot ulcer treated unsuccessfully for at least 4 weeks with mean diameter between 1.5 and 4 cm after débridement | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) LV (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015749-22 | Sponsor Protocol Number: ADATOP | Start Date*: 2010-12-22 | |||||||||||
Sponsor Name:University of Leipzig | |||||||||||||
Full Title: A prospective, monocentric clinical trial with adalimumab for topical treatment in chronic wounds | |||||||||||||
Medical condition: Chronic stasis ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006013-11 | Sponsor Protocol Number: HOTPANTS | Start Date*: 2022-08-29 |
Sponsor Name:Erasmus MC, department of dermatology | ||
Full Title: Hyperbaric Oxygen Therapy for Pyoderma gangrenosum As a New Treatment Strategy | ||
Medical condition: Pyoderma gangrenosum | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000234-57 | Sponsor Protocol Number: allo-APZ2-DFU-II-01 | Start Date*: 2017-08-07 | |||||||||||
Sponsor Name:RHEACELL GmbH & Co. KG | |||||||||||||
Full Title: An interventional, multicenter, single arm, phase I/IIa clinical trial to investigate the efficacy and safety of allo-APZ2-DFU on wound healing of diabetic neuropathic ulcer (DFU). | |||||||||||||
Medical condition: Diabetic neuropathic ulcer (DFU) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000214-42 | Sponsor Protocol Number: 755-201-EB | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:InMed Pharmaceuticals Inc. | |||||||||||||
Full Title: A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa. | |||||||||||||
Medical condition: Epidermolysis bullosa | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) AT (Completed) GR (Ongoing) IT (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003104-39 | Sponsor Protocol Number: SIS-05-2013 | Start Date*: 2013-12-18 |
Sponsor Name:Fakultní nemocnice Ostrava,Czech republic | ||
Full Title: Randomised Clinical Study of Safety of Efficacy of Extracelular Matrix and Autologous Platelet Rich Plasma Concentrate for Wound Healing (Leg Ulcers Biodesign Wound Healing – LEGEND(A) Study) In... | ||
Medical condition: Chronical ischemic and venous ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001672-55 | Sponsor Protocol Number: MW2010-03-02 | Start Date*: 2014-09-22 | |||||||||||
Sponsor Name:MediWound Ltd. | |||||||||||||
Full Title: A multicenter, multinational, randomized, controlled, assessor blinded study, performed in subjects with thermal burns, to evaluate the efficacy and safety of NexoBrid compared to Gel Vehicle and c... | |||||||||||||
Medical condition: The study objective is to evaluate the efficacy and safety of NexoBrid in removing burn eschar in hospitalized subjects with thermal burns. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) RO (Completed) LV (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.